Ivabradine (Corlanor) for Heart Failure: The First Selective and Specific I f Inhibitor.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

28 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis.BMJ evidence-based medicine · 2022
   Pooled it
2. Effects of adding ivabradine to usual care in patients with angina pectoris: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis.Open heart · 2020
   Pooled it
3. Contemporary Antianginal Therapy.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
   Review
4. Efficacy of ivabradine in heart rate reduction after cardiac transplantation: Systematic review and meta-analysis.World journal of cardiology · 2025
   Article
5. Effect of Ivabradine on Heart Failure: A 2024 Meta-Analysis.Cureus · 2025
   Review
6. Ischemia with no obstructed coronary arteries and microvascular testing procedures: a review of utility, pharmacotherapy, and current challenges.Frontiers in cardiovascular medicine · 2025
   Review
7. [The challenging patient-recommendations and solutions].Radiologie (Heidelberg, Germany) · 2024
   Review
8. Screening effects of HCN channel blockers on sleep/wake behavior in zebrafish.Frontiers in neuroscience · 2024
   Article
9. Localization of hyperpolarization-activated cyclic nucleotide-gated channels in the vertebrate retinas across species and their physiological roles.Frontiers in neuroanatomy · 2024
   Review
10. Ivabradine effects in hospitalized acute heart failure patients: a single center retrospective study.American journal of cardiovascular disease · 2023
    Article
11. Expert Consensus on Ivabradine-based Therapy for Heart Rate Management in Chronic Coronary Syndrome and Heart Failure with Reduced Ejection Fraction in India.Current cardiology reviews · 2023
    Article
12. Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19: JACC Review Topic of the Week.Journal of the American College of Cardiology · 2022
    Review
13. Pd(II)-Catalyzed Enantioselective C(spJournal of the American Chemical Society · 2022
    Article
14. Recent Advances on Drug Development and Emerging Therapeutic Agents Through Targeting Cellular Homeostasis for Ageing and Cardiovascular Disease.Frontiers in aging · 2022
    Review
15. Cardioprotective Activity ofEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
16. Use of Preoperative Single Dose Ivabradine for Perioperative Hemodynamic Stabilization During Non-Cardiac Elective Surgery Under General Anaesthesia: A Pilot Study.Journal of clinical medicine research · 2021
    Article
17. MetabolicMolecules (Basel, Switzerland) · 2021
    Review
18. An overview of chiral separations of pharmaceutically active substances by HPLC (2018-2020).Monatshefte fur chemie · 2021
    Review
19. Ivabradine: A Potential Therapeutic for Children With Refractory SVT.Frontiers in cardiovascular medicine · 2021
    Article
20. Simultaneous Optimization of Oral and Transdermal Nanovesicles for Bioavailability Enhancement of Ivabradine Hydrochloride.International journal of nanomedicine · 2021
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract